Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery and Development India

Drug Discovery and Development India

Keynote Speakers

Rathnam Chaguturu
Founder and CEO/Senior Director, SRI International

Amitabha Chattopadhyay
Outstanding Scientist (Director Level), Centre for Cellular & Molecular Biology

Noel de Souza
Consultant, Independent Pharma Drug Discovery & Development

Ahmed Kamal
Outstanding Scientist and Head, Indian Institute of Chemical Technology

Stefan Krauss
Director, University Of Oslo

Sergei Makarov
Chief Executive Officer, Attagene Inc

Prati Pal Singh
Professor, NIPER Mohali

Anu Singh
Vice President R&D, Dabur Research Foundation

J S Yadav
Former Director, Indian Institute of Chemical Technology


SELECTBIO is delighted to announce its 3rd International Conference Drug Discovery India 2015. Drug Discovery India 2015 will be held as three independent conferences at the same venue i.e. Drug Discovery and Development India 2015, MedChem India 2015 and NanoPharmaceuticals scheduled to be held on September 9-11, 2015 in Hotel Radisson Hitec City, Hyderabad. The theme of the conference is "Chemical Biology and Innovative Translational Research" The event aims to expand and integrate your knowledge by providing insights into the latest developments and innovations in field of discovery and development of drugs. Every year this event bring together about 200 drug discovery scientists together at a platform to discuss and share drug discovery related research and facilitates collaborations amongst scientists from across the globe. 

Registered delegates will have unrestricted access to all co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.

Running alongside the Drug Discovery and Development India 2015 conference will be an Exhibition covering the latest technological advances within these fields. We look forward to welcoming you at the Drug Discovery India 2015 Conferences and Exhibition and hope that the two days will be both informative and enjoyable.

Who Should Attend

Drug Discovery Scientists, Medicinal Chemists, Biotechnologists & Researchers from Pharmaceutical Industry R&D and Academic institutions working in the area of New Drug Discovery Research, Discovery and Development of New Chemical entities, Advanced Drug Discovery and Screening Technologies, Drug Target Identification, Structure-based and Target-based, Drug Design, Protein-Protein Interactions, Drug Repurposing, Orphan Drugs, Pre-clinical Drug Development and ADMET Profiling.

This conference will also be of special relevance for

• Scientists, Biotechnologists, Pharmacologists and Researchers from Pharmaceutical/Biotechnology industry and academics working in the areas of Structure-based Drug Design, Synthetic Biology, Chemical Biology, Stem Cell Research for Drug Discovery, Cell Signaling, Cell Based Assays, Epigenetic Drug Discovery, Genomics, Personalized Medicine, Molecular Pharmacology, Target-based Drug Design including Target Identification and Validation, GPCR based Drug Design, Protein-Protein Interactions, Transporters, Kinase and Enzyme Inhibitors etc

• Scientists and Researchers working in the area of Biomolecular Screening and Novel screening methodologies in Drug Discovery like High Throughput Screening, Ultra High Throughput Screening, Phenotypic Screening

• Medicinal Chemists, Pharmacologists & Biotechnologists working in the areas like Infectious & Tropical diseases and Multi-Drug Resistance

Scientists, Clinicians/Doctors and Researchers involved in Drug Discovery and related research in the specialized field of Oncology, Immunology and Biologics including Carbohydrate molecules and Lipidomics

Drug Development, Drug Delivery Scientists working in the field of Pre-Clinical Drug Development including CMC (Chemistry, Manufacturing and Control), ADMET Profiling, DMPK, Assay Development, Toxicology, Lead Optimization,including Novel Salt Forms & Polymorphic forms for a NCE

Agenda Topics

  • Cell Signalling Pathways for Drug Discovery
  • Discovery Approaches for Neglected Tropical Diseases
  • Drug Repurposing, Repositioning and Orphan Drugs
  • GPCR based Drug Design
  • Innovative Translational Strategies to Discover & Develop Drugs
  • Novel Screening Methodologies for Drug Discovery
  • Novel Therapeutic Targets using Chemical Biology
  • Pre-Clinical Drug Development
  • Success in Drug Discovery - Case Studies
  • Targetting Protein-Protein Interactions

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Distinguished Faculty

Punit Srivastava, Assistant Director, Daiichi Sankyo India Pharma Pvt Ltd
Prakash Jha, Assistant Professor, Central University of Gujarat
Subrahmanyam Vangala, Founder and Chief Executive Officer, ReaGene Biosciences Private Limited
Dipak Ramji, Professor, Cardiff University
G Praveen Kumar, Professor & Principal, Sahasra Institute of Pharmaceutical Sciences
Prem M S Chauhan, Professor (AcSIR), Central Drug Research Institute
Sridhar Radhakrishnan , Research Fellow , Cancer Science Institute of Singapore
Rakesh Rawal, Senior Scientific Officer & Head, The Gujarat Cancer & Research Institute
Keshav Deo, Senior Vice President, Wockhardt Research Center
Anamik Shah, Vice Chancellor, Gujarat Vidyapith
Shanavas Alikunju, Vice President & Head - Translational R&D and Biology, Dr. Reddy's Laboratories Ltd

Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks